Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.

BACKGROUND:Neuroblastma cell lines contain a side-population of cells which express stemness markers. These stem-like cells may represent the potential underlying mechanism for resistance to conventional therapy and recurrence of neuroblastoma in patients. METHODOLOGY/PRINCIPAL FINDINGS:To develop n...

Full description

Bibliographic Details
Main Authors:	Barbara Hämmerle, Yania Yañez, Sarai Palanca, Adela Cañete, Deborah J Burks, Victoria Castel, Jaime Font de Mora
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3792090?pdf=render

Similar Items

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
by: Eva María Trinidad, et al.
Published: (2023-05-01)

<i>MTHFR</i> and <i>VDR</i> Polymorphisms Improve the Prognostic Value of <i>MYCN</i> Status on Overall Survival in Neuroblastoma Patients
by: Gladys G. Olivera, et al.
Published: (2020-04-01)

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
by: Gladys G. Olivera, et al.
Published: (2021-09-01)

Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
by: Antonio Juan Ribelles, et al.
Published: (2021-04-01)

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
by: Sultana Parvin, et al.
Published: (2023-04-01)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration
by: Ana P. Berbegall, et al.
Published: (2014-06-01)

Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma
by: Zimmerman, Mark W, et al.
Published: (2023)

Li-Fraumeni: Will the detection in families increase the survival of its members?
by: Pablo Gargallo, et al.
Published: (2019-01-01)

Li-Fraumeni: ¿la detección de familias aumentaría la supervivencia entre sus miembros?
by: Pablo Gargallo, et al.
Published: (2019-01-01)

Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions
by: Nadiya Bayeva, et al.
Published: (2021-03-01)

Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.
by: Yu-Yin Shih, et al.
Published: (2011-01-01)

Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid
by: Anne M. Silvis, et al.
Published: (2016-04-01)

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
by: Silvia Lampis, et al.
Published: (2022-04-01)

The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway.
by: Peihua Luo, et al.
Published: (2011-01-01)

Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
by: Rebeca Burgos-Panadero, et al.
Published: (2019-05-01)

Retinoblastoma and mosaic 13q deletion: a case report
by: Pablo Gargallo, et al.
Published: (2021-09-01)

QUANTITATIVE APPROACH TO ASSIST NEUROBLASTOMA ASSESSMENT BY MEASURING I-123 mIBG UPTAKE IN SCINTIGRAPHIC IMAGES
by: Rafael Martínez-Díaz, et al.
Published: (2015-03-01)

Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer
by: Sangiliyandi Gurunathan, et al.
Published: (2020-09-01)

Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells
by: Roshna Lawrence Gomez, et al.
Published: (2022-09-01)

Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells.
by: Giorgia Mandili, et al.
Published: (2011-01-01)

Retinoic acid regulates the ubiquitin–proteasome system in a middle cerebral artery occlusion animal model
by: Ju-Bin Kang, et al.
Published: (2022-05-01)

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care
by: Pablo Gargallo, et al.
Published: (2021-10-01)

Site-Specific Proteasome Inhibitors
by: Alexei F. Kisselev
Published: (2021-12-01)

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study <sup>‖</sup>
by: Martina Morini, et al.
Published: (2019-09-01)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
by: Nathalie Vigneron, et al.
Published: (2015-09-01)

Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment.
by: Jon Celay, et al.
Published: (2013-01-01)

Data on retinoic acid and reduced serum concentration induced differentiation of Neuro-2a neuroblastoma cells
by: Mukesh Kumar, et al.
Published: (2018-12-01)

Proteasome inhibitors as anti-cancer agents.
by: Murray, R, et al.
Published: (2000)

Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
by: Jinhai Wang, et al.
Published: (2021-10-01)

Nostocyclopeptides as New Inhibitors of 20S Proteasome
by: Anna Fidor, et al.
Published: (2021-10-01)

Proteasome Inhibitors for the Treatment of Multiple Myeloma
by: Shigeki Ito
Published: (2020-01-01)

Non-Covalent Inhibitors of the 20S Proteasome
by: Carlos García-Echeverría, et al.
Published: (2003-04-01)

Consulta de seguimiento activo de supervivientes de cáncer pediátrico
by: Adela Cañete, et al.
Published: (2009-01-01)

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
by: Diego Acosta-Alvear, et al.
Published: (2015-09-01)

P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors
by: Andressa Barban do Patrocinio, et al.
Published: (2022-01-01)

Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review
by: Jaume Mora
Published: (2022-05-01)

XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB
by: Basia Galinski, et al.
Published: (2021-08-01)

Proteasome inhibitors: new class of antitumor agents
by: Gordan Srkalović
Published: (2003-11-01)

Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment
by: Cassidy M. Van Stiphout, et al.
Published: (2022-09-01)

New proteasome inhibitors in the management of multiple myeloma
by: S. V. Semochkin
Published: (2019-07-01)